Upgrades:
Downgrades:
Merck (MRK) downgraded to Market Perform from Outperform at BMO Capital; target $62
Other:
Intel (INTC) target raised to $36 from $34 at RBC Capital Mkts
Intel (INTC) target raised to $40 from $38 at Canaccord Genuity
Yandex N.V. (YNDX) initiated with a Buy at HSBC Securities